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ABSTRACT
Chlorpyrifos is an organophosphorus insecticide that elicits acute toxicity through inhibition of acetylcholinesterase
(AChE), leading to acetylcholine accumulation and prolonged stimulation of cholinergic receptors throughout the central
and peripheral nervous systems. Previous studies have indicated that neurodevelopment may also be impaired through
alternative pathways, including reduction of cyclic adenosine monophosphate (cAMP)-catalyzed downstream events. The
upstream initiating events that underlie noncholinergic neurological actions of chlorpyrifos and other organophosphorus
compounds remain unclear. To investigate the potential role of fatty acid signaling disruption as a mechanism of toxicity,
lipid metabolism and fatty acid profiles were examined to identify alterations that may play a critical role in upstream
signaling in the central nervous system (CNS). Juvenile rainbow trout were treated for 7 days with nominal chlorpyrifos
concentrations previously reported to diminish olfactory responses (10, 20, and 40lg/l). Although lethality was noted higher
in doses, measured chlorpyrifos concentrations of 1.38lg/l (nominal concentration 10lg/l) significantly reduced the activity
of AChE and two serine lipases, monoacylglycerol lipase, and fatty acid amide hydrolase in the brain. Reductions in
lysophosphatidylethanolamines (16:0, 18:0, 18:1, and 22:6) derived from the phosphatidylethanolamines and free fatty acids
(palmitic acid 16:0, linolenic acid 18:3, eicosadienoic acid 20:2, arachidonic acid 20:4, and docosahexaenoic acid 22:6) were
also noted, suggesting that chlorpyrifos inhibited the metabolism of select phospholipid signaling precursors at sublethal
concentrations. These results indicate that in addition to AChE inhibition, environmentally relevant chlorpyrifos exposure
alters serine lipase activity and lipid metabolites in the trout brain, which may compromise neuronal signaling and impact
neurobehavioral responses in aquatic animals.
Key words: pesticide; neurotoxicology; organophosphate; lipidomics.
Chlorpyrifos (O,O-diethyl O-3,5,6-trichloropyridin-2-yl phos-
phorothioate, CPF) is an organophosphate insecticide that is
widely used for agriculture purposes in the United States and
around the world. Its residential use has been restricted in the
United States since 2000, primarily due to developmental neuro-
toxicity studies in rodents and epidemiological studies in
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humans suggesting significant risk to the developing brain
(Campbell et al., 1997; Qiao et al., 2003; Rauh et al., 2006).
Numerous studies have shown that CPF is bioactivated by cyto-
chrome P450 monooxygenases to its corresponding oxon, a po-
tent irreversible inhibitor of acetylcholinesterase (AChE) (Amitai
et al., 1998), responsible for the breakdown of the neurotrans-
mitter acetylcholine. Reduced AChE following CPF exposure
leads to hyperactivity at cholinergic synapses in neurons and
neuromuscular junctions (Sandahl et al., 2005; Sultatos, 1994).
High exposures in mammals can cause acute lethality due to re-
spiratory failure from both central and peripheral actions
(Eddleston et al., 2006). The cause of death in fish is less certain.
Measurable concentrations of CPF have been detected in
many waterways along the western coast of the United States
(Sargeant et al., 2013; Zhang et al., 2012), generally at concentra-
tions well below those necessary to induce acute lethality in
fish. Therefore, recent attention has focused on the effects of
chronic, lower-level CPF exposures. The behavioral effects of
AChE inhibition following sublethal CPF exposure have been
well-documented in several fish species, with effects on swim
performance, feeding, predatory cue detection, and overall ac-
tivity (Levin et al., 2004; Rice et al., 1997; Sandahl et al., 2005;
Tierney et al., 2007). Loss of predatory cue detection has been as-
sociated with reduced predator avoidance and increased mor-
tality risk (McIntyre et al., 2008, 2012).
Recent evidence has suggested other sublethal impacts of
CPF in the developing brain that are unrelated to AChE inhibi-
tion. Specifically, altered signal transduction in the olfactory
bulb may be related to declines in odor-evoked behaviors in
CPF-exposed fish. Olfactory function in zebrafish is disrupted by
CPF through inhibition of G-protein-coupled receptor signaling
and odorant binding, leading to reduced olfactory responsive-
ness (Tilton et al., 2011). Genes involved in second messenger
signaling, neurotransmitter signaling, and calcium signaling
were consistently downregulated in salmon with reduced odor
avoidance behaviors (Wang et al., 2016), and the magnitude of
overevoked field potentials was inhibited in electrophysiologi-
cal recordings in response to CPF (Sandahl et al., 2004). Previous
studies in our laboratory using rainbow trout have indicated
that reduced physiological and behavioral responses following
CPF exposure correspond with transcriptomic changes in the
brain for genes involved in neuronal signal transduction and
are associated with diminished cAMP and calcium signaling
(Maryoung et al., 2014).
The initiating events for transcriptomic changes associated
with CPF exposure are unclear. However, recent developments
in lipidomic methodologies have indicated that novel free fatty
acids (FFAs) derived from lipids either from plasma or from or-
ganelle membranes can have significant impacts on transcrip-
tional regulation (Jump, 2004). Free fatty acids bind to nuclear
receptors in a manner similar to hydrophobic hormones
(Go¨ttlicher et al., 1992) and can directly affect gene transcription
through peroxisome proliferator activated receptors (PPARs)
and NF-jB (Bocos et al., 1995). Each of these signaling pathways
can alter expression of genes important in neuronal signaling
and cognitive function (Bright et al., 2008). Indirect effects of FFA
on transcription can occur via effects on protein kinase C (PKC)
signal transduction and changes in membrane lipid composi-
tion, altering G-protein-coupled receptors (Jump, 2004). Protein
abundance and mRNA turnover rate can also be affected by
FFAs (Duplus et al., 2000; Jump, 2004). The summation of FFA-
induced changes can alter cellular growth, differentiation, sig-
naling, and metabolism (Diascro et al., 1998).
Alterations in FFA and other lipids in the brain following CPF
exposure may occur through serine lipase inhibition. FFA con-
tent is regulated by a number of serine hydrolases that cleave
ester bonds anchoring fatty acids to the glycerol backbone.
Previous studies have shown that organophosphate oxons,
such as CPF-oxon, can bind to and inhibit serine hydrolases in a
similar manner as AChE (Deutsch et al., 1997; Quistad et al.,
2006). Inhibition of hydrolases/lipases by CPF could alter the
population and distribution of FFAs as well as other lipid-
derived molecules in the brain, initiating FFA-induced tran-
scriptional changes. Monoacylglycerol lipase (MAGL) and fatty
acid amide hydrolase (FAAH) are two serine lipases highly sen-
sitive to many organophosphate oxons, and inhibition of FAAH
or MAGL in mice drastically alters the brain lipidome, an effect
that varies greatly by brain region (Leishman et al., 2016).
In order to test the hypothesis that CPF inhibits serine
hydrolases in rainbow trout brain that are important in regulat-
ing lipid signaling at concentrations previously reported to im-
pair neurological function, juvenile rainbow trout were exposed
to CPF for 7 days. Following treatment, the brains were evalu-
ated for activities of the cholinesterases (AChE and its “sister”
enzyme butyrylcholinesterase, BChE), activities of the serine
lipases MAGL and FAAH, and changes in lipid profiles. Ex vivo
inhibition of AChE and BChE by chlorpyrifos oxon was also com-
pared. Alterations in lipidomic content and serine lipases in-
duced by CPF were examined in the context of their potential
impacts on neuronal signaling pathways in the developing
brain.
MATERIALS ANDMETHODS
Exposures. After acclimation for 1 month, juvenile rainbow trout
(parr stage, mean 6 SEM, mass= 54.064.4 g, length¼ 17.4 6
1.5 cm, n¼ 33) from Jess Ranch Hatchery (Apple Valley,
California) were placed in 20-l glass aquaria (1 fish per aquaria)
for 7 days in 12C water with a 14:10 light dark cycle. Aquaria
were placed on an exposure table with a recirculating chiller to
maintain 12C water temperature. Chlorpyrifos (99.5% purity,
Chem Services, West Chester, Pennsylvania) was dissolved in
100% ethanol, with stock solutions kept in the dark at 20˚C.
Exposure solutions were prepared by diluting a working stock
solution with dechlorinated water, with a final vehicle concen-
tration <0.01% ethanol within all treatment groups and vehicle
control. Exposure groups included a solvent control (0.01% etha-
nol) and nominal CPF treatments of 10, 20, and 40 lg/l for mor-
tality range finding, with an n of 8 animals per treatment group.
Fifty percent water changes were performed daily and replaced
with fresh water. A stock CPF solution was then spiked into
each exposure aquarium to maintain initial nominal concentra-
tions of CPF. Trout were fed Skretting trout food every 48 h prior
to re-exposure and allowed 2 h to consume the food. Each ani-
mal was fed 3% of its body weight and the remaining food was
siphoned out during the daily water change. After 7 days, brains
from remaining live fish from sublethal concentrations were re-
moved for biochemical and lipidomic measurements. Brain
removals were conducted by first euthanizing an animal in tri-
caine methane sulfonate (MS-222, Argent Chemical
Laboratories, Redmond, Washington), followed by cervical dis-
location on the bench top. Tissues were immediately flash fro-
zen in liquid nitrogen following extraction. Concentrations of
CPF and duration of exposure were based on previous studies
showing impairment of electrophysiological olfactory function
and behavior (Maryoung et al., 2014; Sandahl et al., 2004).
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Experimental protocols were approved by the University of
California Riverside Institutional Animal Care and Use
Committee (A-20130010). Sex was not determined for the
animals.
Water chemistry analysis. Water samples were collected through-
out the duration of the exposure at the same time each morning
(8:00), prior to the daily water change, and stored at 4C in 1-
l amber glass bottles. Samples were processed within 1 week of
sampling. Extractions were performed in accordance with
Environmental Protection Agency (EPA) method 3510C. Briefly,
1 l of sample was mixed with 50 ml methylene chloride (Thermo
Fisher Scientific) in a separatory funnel and shaken for 2.5 min.
Following phase separation, the lower methylene chloride layer
was drained and filtered through a layer of burned anhydrous
sodium sulfate into a round-bottom flask. This extraction was
repeated 2 more times, for a total of 3 times, and all extractions
were combined. The sample was dried down on a
Rotevaporator to approximately 1 ml and the flask was rinsed
with hexane, then further dried under nitrogen. The sample
was reconstituted in 1 ml hexane and stored at 20C until
analysis. Samples were run on an Agilent 6890N/5973B GC/MSD
with a 30 m  0.25 m DB-5MS column with the following param-
eters: Initial temperature of 80C for 1 min, followed by a tem-
perature increase to 200C at a rate of 25C/min, increased to
300C at a rate of 5C/min and held at 300C for 9 min. Helium
was used as the carrier gas under a flow rate of 1.2 ml/min. A 6-
point standard curve was used to determine sample concentra-
tions with serial dilutions of an internal standard.
PCB 209 was used as an internal standard and added to
each sample prior to extraction. Although PCB 209 is a very hy-
drophobic compound with a log Kow of around 8, it has com-
monly been used as a surrogate standard in studies of
pyrethroid insecticides and other hydrophobic pesticide
products.
Cholinesterase and serine lipase assays. Brain tissues were homog-
enized 1:10 (w/v) in phosphate buffered saline (100 mM phos-
phate containing 1.54 M NaCl, pH 7.4) for measurements of
AChE, BChE, MAGL, and FAAH activity. AChE, BChE, and
MAGL were measured using a photometric assay (Anderson
et al., 2018) based on the method of Ellman et al. (1961). A
cocktail containing substrate (1 mM acetylthiocholine, 1 mM
butyrylthiocholine, or 0.1 mM 2-arachidonoyl thioglycerol)
and 0.1 mM 5,50-dithio-bis-(2-nitrobenzoic acid) in Tris-E
(10 mM Tris-HCl containing 1 mM EDTA, pH 7.2) was added to
start the reaction. Change in absorbance at 412 nm was mea-
sured for 5 min at 25C using a Spectramax M2 microplate
reader (Molecular Devices; Sunnyvale, California). Enzyme ac-
tivity was estimated based on the rate of appearance of the
reaction product, 2-nitro-5-thiobenzoate (e¼ 14, 150 M1 cm1).
FAAH activity was measured in a plate reader-based fluoro-
metric assay (Huang et al., 2007). Tissue homogenates were
added into a plate with 125 mM sodium phosphate buffer con-
taining 1% glycerol and 0.1% Triton-X-100, pH 8.0. The reac-
tion was started by the addition of 0.5 mM N-(6-
methoxypyridin-3-yl) octanamide (OMP) (dissolved in 1:1
DMSO/EtOH) and incubated for 30 min at 25C. Following incu-
bation, the fluorescence intensity of the product (5-amino-2-
methoxypyridine [AMP]) was measured (excitation: 320 nm,
emission: 396 nm). A contemporaneous standard curve of
AMP was used to convert relative fluorescence units (RFU) to
nmol of product. OMP was a generous gift from Dr Bruce
Hammock, UC Davis. All enzyme activities were normalized
to protein concentration using the method described by
Bradford (1976) and bovine serum albumin as the standard.
Ex vivo AChE and BChE inhibition assays. Ex vivo sensitivity of
AChE and BChE to inhibition by chlorpyrifos oxon was evalu-
ated similarly to Johnson and Russell (1975). Frozen brain tissue
was homogenized 1:30 (w/v) in 50 mM potassium phosphate
buffer, pH 7.0 (KPi). Equal volumes of homogenate and either ve-
hicle (KPi containing 1% ethanol; KPi/EtOH) or one of a range of
concentrations of CPF-oxon (0.6 nM–1 lM in KPi/EtOH) were
mixed and preincubated for 20 min at room temperature.
Following preincubation, the reaction was started by addition of
[3H]acetylcholine or [3H]butyrylcholine (1 mM final concentra-
tion). [3H]acetylcholine iodide (specific activity 65.5 mCi/mmol)
and [3H]butyrylcholine iodide (specific activity 95 mCi/mmol)
were purchased from Perkin Elmer (Waltham, Massachusetts).
Reactions proceeded at room temperature for 10 min (AChE) or
360 min (BChE) and were terminated by addition of an acidified
stop solution, followed by extensive vortexing. A hydrophobic
scintillation cocktail was added and product ([3H]acetic acid)
was separated by liquid-liquid exchange and then counted in a
scintillation counter (Perkin Elmer Tri-Carb 2810 TR; 61% effi-
ciency). Preliminary assays were conducted to determine the
appropriate tissue concentration and incubation time to capture
a linear rate of substrate hydrolysis. Data from three indepen-
dent samples were normalized based on vehicle controls (100%
activity) and fit using a variable slope nonlinear regression
model to estimate half maximal inhibitory concentration (IC50)
and 95% confidence intervals (Graphpad Prism version 6.07; La
Jolla, California).
Lipid extraction and analysis. Samples were homogenized in phos-
phate buffer saline (10:1, w/v) using a glass homogenizer. An ali-
quot of 50 ml of each sample was added into a glass vial followed
by addition of deuterated internal standards (SPLASH mix,
Avanti, Alabama). Lipid extraction was accomplished by the
Bligh and Dyer (1959) method using water:methanol:chloroform
(2:1:1.5 v/v/v). The lower layer chloroform was collected, con-
centrated to dryness, and reconstituted into 100 ml
MeOH:toluene (9:1 v/v) prior to analysis.
Separation and quantification of lipid classes was performed
on an AB Sciex Qtrap 6500 LC-MS/MS using a hydrophilic inter-
action liquid chromatography (HILIC) column. LC conditions
were operated at a flow rate of 0.5 ml/min and a gradient con-
sisting of acetonitrile:water (95:5 v/v) (A) and acetonitrile:water
(50:50 v/v) (B) with 10 mM ammonium acetate. Scheduled multi-
ple reaction monitoring (sMRM) was used for identification of
lipid classes (eg, phospholipids, sphingolipids, glycerols, and
FFAs).
RESULTS
Mortality and Water Chemistry Analysis
Nominal CPF concentrations of 10, 20, and 40 lg/l were used for
mortality range finding for sublethal CPF concentrations in rain-
bow trout. Seventy five percent mortality was observed in both
20 and 40 lg/l CPF treatments, with no acute mortality observed
in control or 10 lg/l CPF exposures. Therefore, all subsequent
chemical and biochemical analyses were performed at a nomi-
nal CPF concentration of 10 lg/l.
Measured CPF concentration in the solvent controls was
below the detection limit at all sampling timepoints.
Measured CPF concentration from the 10 lg/l nominal
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concentration, taken over the duration of the exposure, were
1.38 6 2.58 lg/l. Recovery values, calculated from a PCB 209
standard, were 104% 6 16.9%. The 10 lg/l nominal CPF con-
centration will be presented as the measured concentration
throughout.
Biochemical Changes
Brain AChE was significantly inhibited in animals exposed to
1.38 lg/l CPF (40% inhibition, Figure 1). The basal activity of
BChE was significantly lower than AChE activity in trout brain
and was not inhibited in vivo by CPF (control BChE activity:
0.646 nmol min1 mg1 6 0.04; 1.38 lg/l CPF activity: 0.694 nmol
min1 mg1 6 0.03). To further test the sensitivity of AChE and
BChE to CPF-oxon, ex vivo inhibition of each enzyme was deter-
mined (Figure 2). IC50 values (25C, 20 min) and 95% confidence
intervals were calculated. In contrast to the in vivo findings,
AChE and BChE appeared relatively similar in sensitivity to CPF-
oxon ex vivo (AChE, IC50 ¼ 43.7 nM [39.72–48.13]; BChE, IC50 ¼
50.1 nM [47.24–53.07]).
Activity of two serine lipases, MAGL and FAAH, were also
assessed at the sublethal dose of 1.38 lg/l CPF. MAGL activity
was significantly decreased (84% inhibition) by CPF at 1.38 lg/l,
and FAAH activity was also significantly reduced following ex-
posure (24% inhibition; Figure 3).
Lipidomics
Lipids were separated by HILIC chromatography based on their
retention times. Targeted analysis of lipids was performed us-
ing 1300 sMRMs in both positive and negative mode and lipids
were graphed based on lipid categories. No significant differen-
ces were observed between controls and trout exposed to CPF
(1.38 lg/l) for sphingomyelins, phosphatidylcholines, or lyso-
phosphatidylcholines. However, reductions were noted for lyso-
phosphatidylethanolamines (LPEs), triacylglycerides (TAG),
FFAs, and phosphatidylethanolamines (PE).
Free fatty acids showed the greatest reduction in CPF-
treated animals (Table 1). Reductions were observed in a num-
ber of lipids including 16:0, 18:3, 20:2, 20:4, and 22:6. Significant
reductions were also noted for 4 out of the 5 LPEs measured,
including the 16:0, 18:0, 18:1, and 22:6 compounds (Figure 4A).
This was accompanied by a trend toward an increase in the
parent PE (P16:0/18:1), suggesting a reciprocal parent/daughter
relationship (Figure 4B). Significant decreases were observed
for 2 other PEs, PE (18:1/20:5) and PE (P18:0/16:1). A significant
decrease was also noted for 2 TAGs (TAG52:4-FA18:2 and
TAG52:3-FA18:1) in the brains of CPF-treated animals
(Figure 5). Notably, TAG52:3-FA18:1 was highly concentrated in
control brains (5.85 lM) but was absent in the brain of CPF-
treated animals.
DISCUSSION
In order to evaluate the molecular initiating event for impaired
signal transduction observed in previous sublethal studies with
CPF in fish (Maryoung et al., 2014; Wang et al., 2016), a lipidomic
screen and evaluation of serine hydrolase enzymes important
in the cleavage of FFAs and other signaling lipids from glycerol
backbones was carried out. Lipidomic evaluations were con-
ducted at the sublethal concentration of 1.38 lg/l CPF, where
AChE, MAGL, and FAAH activities were significantly reduced,
without inducing acute lethality. Concentrations exceeding
3 lg/l have been measured in the San Jaoquin region in
Figure 1. Acetylcholinesterase inhibition following chlorpyrifos (CPF) exposure.
Acetylcholinesterase activity in brain from rainbow trout exposed to 1.38 lg/l CPF
for 7 days. (*p .05, unpaired t test, two-tailed, n¼4 per treatment group).
Figure 2. Ex vivo inhibition of acetylcholinesterase (AChE) and butyrylcholines-
terase (BChE) by chlorpyrifos (CPF)-oxon. Brain tissue from untreated juvenile
rainbow trout was used to assess the sensitivity of AChE and BChE to ex vivo in-
hibition by CPF-oxon. The data represent the mean 6 SEM (n¼3 replicates per
treatment group).
Figure 3. Inhibition of monoacylglycerol lipase (MAGL) and fatty acid amide hy-
drolase (FAAH) by chlorpyrifos (CPF). Inhibition of MAGL and FAAH activity in
rainbow trout brain tissues following whole-animal exposure to CPF for 7 days.
Values represent mean 6 SEM (*p .05, unpaired t test, two-tailed, n = 3 per
treatment).
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California, thus the CPF concentration used in this study repre-
sents an environmentally relevant scenario.
Measured CPF concentrations of 1.38 lg/l resulted in 40% in-
hibition of AChE in rainbow trout brains compared with con-
trols. Inhibition of AChE by CPF has been observed with
concentrations as low as 0.4 mg/l for 96 h in the brain of coho
salmon (Sandahl et al., 2005), and concentrations less than one
part per billion (approximately 1 lg/l) in steelhead (Sandahl and
Jenkins, 2002), thus it was unsurprising that AChE was signifi-
cantly inhibited in rainbow trout in this study. Although both
AChE and BChE appeared similar in sensitivity to CPF-oxon ex
vivo, BChE activity levels in the brain were near the limit of de-
tection, indicating that BChE may not be present in the rainbow
trout brain. This corroborates other studies showing that AChE
is the predominant cholinesterase source in the brain in rain-
bow trout and other Salmonidae species (Sandahl et al., 2005;
Sandahl and Jenkins, 2002; Sturm et al., 2007) and suggests that
cholinesterase-induced alterations in the brain of CPF-exposed
rainbow trout are likely due exclusively to AChE inhibition.
Reduced behavioral responses to olfactory cues following
CPF exposure suggest CPF alters neuronal signaling in the olfac-
tory bulb. However, cholinergic synapses have not been identi-
fied in olfactory rosettes (Scholz et al., 2006), and reduced
reception to predatory cues occurs in the absence of AChE inhi-
bition, suggesting a non-AChE mechanism of action. Other
studies have indicated inhibition of olfactory receptor neuron
signaling pathways, alterations in downstream cAMP-catalyzed
events, and altered Ca2þ regulation following CPF, each inde-
pendent of neuromuscular impairment and AChE inhibition
(Maryoung et al., 2014; Wang et al., 2016).
An alternative pathway may be alterations in lipid-derived
signaling molecules. In addition to AChE, 1.38 lg/l CPF inhibited
both MAGL and FAAH in the brain of treated animals. MAGL and
FAAH are membrane-bound serine hydrolases that hydrolyze 2-
arachidononylglycerol (2-AG) and 2-arachidonoylethanolamine
(AEA), respectively, the two endogenous ligands of cannabinoid
receptors in the brain. Repeated low-dose CPF exposure also
inhibits MAGL and FAAH in the forebrain of juvenile rats, lead-
ing to elevated 2-AG and AEA levels that could disrupt proper
endocannabinoid (eCB) signaling that is crucial to proper brain
development in juveniles (Anavi-Goffer and Mulder, 2009; Carr
et al., 2011). Moreover, FAAH inhibition and increased AEA levels
occur at low CPF concentrations that do not elicit cholinesterase
inhibition (Carr et al., 2014). We also observed greater inhibition
of MAGL (84%) than AChE (40%) in rainbow trout. Although
other enzymes may also play a role in AEA and 2-AG hydrolysis
(Blankman et al., 2007), organophosphate inhibition of MAGL
Figure 4. Lysophosphatidylethanolamine (LPE) and phosphatidylethanolamine (PE) concentrations following exposure. Concentrations of (A) LPEs and (B) PE in the
brain of control and chlorpyrifos (CPF)-treated trout (1.38lg/l for 7 days). Values represent the mean 6 SE (controls, n¼6; 1.38lg/l CPF, n¼4, *p .05, unpaired t test,
two-tailed).
Table 1. Free Fatty Acid Concentrations
Free Fatty
Acid
Control
Concentration
(lM)
1.38 lg/l CPF
Concentration
(lM)
% Change
14:0 0.24 6 0.09 0.16 6 0.02 # 33
14:1 0.18 6 0.05 0.14 6 0.02 # 22
*16:0 3.81 6 0.61 0.66 6 0.14 # 83
16:1 0.51 6 0.18 0.29 6 0.18 # 43
16:2 0.36 6 0.09 na na
18:0 1.89 6 0.80 0.87 6 0.19 # 54
18:1 2.07 6 1.08 0.77 6 1.08 # 63
18:2 0.37 6 0.12 na na
*18:3 0.27 6 0.07 0.12 6 0.05 # 56
20:0 1.57 6 0.23 1.18 6 0.21 # 25
20:1 0.61 6 0.23 0.42 6 0.07 # 31
*20:2 0.28 6 0.06 0.12 6 0.03 # 57
20:3 0.41 6 0.13 0.21 6 0.06 # 49
*20:4 5.23 6 1.87 1.89 6 0.59 # 64
20:5 12.77 6 7.64 6.03 6 1.90 # 53
22:4 0.36 6 0.10 0.17 6 0.00 # 53
22:5 3.17 6 1.07 1.41 6 0.42 # 56
*22:6 35.46 6 11.11 15.75 6 4.50 # 56
24:0 0.30 6 0.10 0.20 6 1.04 # 33
24:1 1.08 6 0.50 0.83 6 0.19 # 23
Free fatty acid concentrations from brain tissues following CPF exposure for 7
days. Values represent the mean 6 SE. Na indicates that the concentration was
below the detection limit (controls, n¼6; 1.38 lg/l CPF, n¼4, * p .05, unpaired t
test, two tailed).
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and FAAH results in elevations in >1000% elevation in 2-AG and
AEA and cannabinoid behavioral effects in mice (Nomura et al.,
2008). Thus, although the analytical methods used in this study
were not suitable for measuring tissue eCBs, FAAH and MAGL
inhibition noted here suggests that elevated concentrations of
AEA and 2-AG may occur in the brain of CPF-exposed trout, with
potential alterations in eCB signaling and related signaling
pathways.
Altered eCB signaling via serine lipase inhibition in the olfac-
tory bulb could be involved in diminished olfactory behavioral
responses following CPF exposure (Maryoung et al., 2014).
Overactivation of eCB signaling suppresses excitatory transmis-
sion in the nervous system via reduced glutamate release
(Pouille and Schoppa, 2018), and cannabinoid receptors are
highly expressed in excitatory corticofugal feedback (CFF) neu-
rons in the olfactory bulb that make connections onto glutama-
tergic neurons involved in odor-evoked output and odor-driven
behaviors (Boyd et al., 2015; Martin et al., 2004; Otazu et al., 2015).
Thus, overactivation of eCB signaling and suppression of neuro-
transmission between CFF and glutamatergic neurons could
play a direct role in diminished olfactory behavioral responses
and inhibition of olfactory receptor neuron signaling pathways
in CPF-exposed fish (Maryoung et al., 2014; Wang et al., 2016).
Cannabinoid receptor 1 (CB1) agonist suppression of transmis-
sion is greater in juvenile rats than adults, suggesting juvenile
trout may also be more susceptible than older trout (Kang-Park
et al., 2007). Furthermore, the G-protein-coupled cannabinoid
receptors are primarily of the Gi and Go classes, which rapidly
decrease cAMP levels by inhibition of adenylyl cyclase activity
(Howlett et al., 2004). Overactivation of eCB signaling would sup-
port transcriptional evidence of diminished cAMP-catalyzed
events observed previously and could play a role in altered
olfactory signal transduction in juvenile rainbow trout
(Maryoung et al., 2015).
CPF exposure at concentrations eliciting serine lipase inhibi-
tion led to significant reductions in the concentration of specific
lipids in the brain, most notably in the overall reduction of
FFAs. The reduction in FFA may be related to the observed inhi-
bition of MAGL. Inhibition of MAGL in PC3 and DU145 cell lines
leads to accumulation of MAGs and subsequent reductions in
their corresponding FFAs, including C20:4 and 16:0 that were al-
tered in this study (Nomura et al., 2011). This is consistent with
previous observations of FAAH and MAGL inhibition altering
brain lipid content in mice (Leishman et al., 2016).
Docosahexaenoic acid (DHA; FFA 22:6 n-3) comprises 40% of the
poly unsaturated fat in the human brain (Singh, 2005) and was
also the most abundant FFA in the brain of rainbow trout.
Docosahexaenoic acid showed significant decreases in the brain
of CPF-treated animals, which has also been implicated in al-
tered eCB signaling through CB1 (Pan et al., 2011; Watanabe
et al., 2003). However, another FFA with a trend toward de-
creased concentration, eicosapentaenoic acid (EPA, FFA 20: 5),
causes the opposite results, with decreased expression on CB1
following treatment. This suggests a complex relationship be-
tween FFA changes and altered eCB signaling in the brain.
Further studies are needed to determine how the summation of
FFA changes alter eCB signaling in the olfactory bulb, and how
these may be related to altered behavioral responses in trout.
Deficiencies in DHA have been implicated in other cognitive
declines through effects on ion channel activity, neurotransmis-
sion, and importantly, deficiencies in the acquisition of an olfac-
tory learning set (Catalan et al., 2002; Lukiw et al., 2005). In
membrane phospholipids it can affect membrane receptor activi-
ties and cell signaling (Akbar et al., 2005). Similar findings have
also been reported for other FFAs showing significant declines in
this study. Palmitic acid (FFA 16:0) deficiency alters serotonin re-
ceptor densities in the frontal cortex in rats, again suggesting
alterations in learning (Delion et al., 1994). Palmitic acid deficiency
also leads to declines in visual acuity in infant rhesus monkeys
(Neuringer et al., 1984). Arachidonic acid (FFA 20:4) can activate
PKCa, inducing mitogenic signaling via activation of Fos, Jun, and
AP-1 transcription factors. Other FFAs with reduced concentra-
tions, eicosadienoic acid (FFA 20:2) and linolenic acid (FFA 18:3),
were very minor components of the lipidome, and little is known
about their importance in the trout brain.
Changes in FFA in the brain can directly alter gene expres-
sion through transcription factors, particularly through PPARs,
PPARa and PPARc, part of the steroid hormone receptor subfam-
ily (O’Sullivan, 2016). All PPAR subtypes bind C16-C20 fatty acids
(Xu et al., 1999), of which four showed deceased concentrations
in CPF animals. PPARs form heterodimers with retinoid X recep-
tor and bind to their constituent response elements in the DNA,
leading to changes in transcription of genes involved in cell dif-
ferentiation, fatty acid metabolism, and neuronal function
(Menendez-Gutierrez et al., 2012; Schoonjans et al., 1995). PPARc
mRNA is expressed at high levels in the olfactory bulb of adult
Figure 5. Triacylglyceride (TAG) concentrations following chlorpyrifos (CPF) exposure. The sum total of all TAGs was significantly decreased in CPF-exposed animals.
Values represent the mean 6 SE (controls, n¼ 6; 1.38lg/l CPF, n¼4, *p .05, unpaired t test, two tailed).
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mice (Liu, Huang, et al., 2015) and plays an important role in de-
velopment and lipid metabolism (Peters et al., 2000). Activation
of PPARa may also have neuroprotective effects and reduce per-
meability of the blood-brain barrier (Hind et al., 2015; Zhou et al.,
2012). Inhibition of FAAH observed may further affect PPAR sig-
naling. FAAH in the brain hydrolyzes palmitoylethanolamide
(PEA) and oleoylethanolamide (OEA), 2 other PPAR agonists
(Leishman et al., 2016). Inhibition of FAAH led to increased PEA
and OEA in rat brain (Liu, Parsons, et al., 2015), which could fur-
ther alter PPAR signaling if these metabolites are altered in trout
following CPF exposure. Other studies have reported that CPF
alters expression of transcription factors (AP1 and Sp-1) in the
developing brain of neonatal rats, indicating that CPF interferes
with brain development through transcription factors involved
in cell replication and differentiation (Crumpton et al., 2000).
Although there is no reported evidence of FFA effects on AP1 or
Sp-1, these results suggest CPF-induced transcription factor
changes occur and could alter associated signaling in the brain.
Activation of PPARa is a major regulator of both intra- and
extra-cellular lipid metabolism by increasing the size and num-
ber of peroxisomes, responsible for cholesterol and lipid metab-
olism (Michalik et al., 2006), and activation of lipoprotein lipase
gene expression, important players in triglyceride metabolism.
Triacylglycerides are synthesized from 3 fatty acid molecules
bonded to the C1-C3 positions in a glycerol “backbone” and are
the primary form of fat energy storage in adipose tissue. This
may in part explain our observation of an overall decrease in tri-
glycerides. Reduced FFAs could mean less material to form
TAGs, combined with increased PPAR activity and metabolism
of present TAGs. Triacylglyceride can be used as a fuel source
for the brain by the metabolism of the glycerol backbone into
glucose. There are little data about the effects of TAGs on brain
activity, thus it is difficult to predict the impacts of reduced TAG
concentrations in the brain due to CPF.
Although ethanolamides were not measured in the current
study, significant differences were observed with LPEs at nearly
every carbon length. Lysophosphatidylethanolamine can be
generated from PE, a component of the cell membrane, via a
phospholipase A-type reaction. In typically low concentrations
in human serum, LPE has been shown to activate MAPK in fungi
and initiate neuron differentiation in PC12 cells (Nishina et al.,
2006). However, it is unclear if altered LPE and PE could affect
neuronal processes in vivo.
To our knowledge, this is the first study to identify serine li-
pase inhibition and lipidomic changes as effects of CPF expo-
sure on the developing brain of fish. Non-AChE mediated
alterations in transcriptional regulation have previously been
implicated in neuronal deficits and reduced prey behavior. The
inhibitory effects of CPF on serine lipases and downstream lipi-
domic profiles indicate potential upstream pathways, such as
eCB and PPAR signaling, that could initiate transcriptomic
changes that ultimately lead to behavioral deficits. Moreover,
MAGL inhibition was more severe than AChE inhibition at low
CPF concentration. These data have important implications for
sublethal effects of CPF on juvenile fish that could affect sur-
vival in the wild.
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